yana-notes

H3

2022-01-25 links: Histamine GPCR reference:

H3 #

Heteromers #

  • [Heteroreceptor Complexes Formed by Dopamine D 1, Histamine H 3, and N-Methyl-D-Aspartate Glutamate Receptors as Targets to Prevent Neuronal Death in Alzheimer’s Disease]
    • Forms heteromers with D1.
    • D1 or H3 receptors form heteromers with NR1A/NR2B NMDA receptor subunits.. D1-H3-NMDAR complexes were confirmed.
    • H3 receptor antagonists reverted the toxicity induced by Aβ-42-amyloid peptide.
  • [The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons]
    • H3 agonist treatment did not detectably alter extracellular DA levels or signaling through the cAMP/DARPP-32 signaling pathway in either D1- or D2-expressing striatal medium spiny neurons (MSNs). In D1-MSNs, H3 agonist treatment transiently activated MAPK signaling and phosphorylation of rpS6 and led to phosphorylation of GSK3β-Ser9, a novel effect
  • [Dopamine D1-histamine H3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal Pathway]
    • H3 activation stimulates p44 and p42 ERK1/2 phosphorylation only in D1-excpressing mice.
  • [Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors]
    • They exhibit a Gi-dependent MAPK cascade.